MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0049521
Prodev Pharma (OPC) Private Limited
Prodev Pharma (OPC) Private Limited - chemicals in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.56 Cr
▼ 45% YoY
Net loss · FY 2025
₹1.54 Lakh
Net margin -0.6%
EBITDA · FY 2025
₹4.25 Lakh
EBITDA margin 1.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
1
As per MCA filings
Active GSTINs
1
GST registered
About Prodev Pharma (OPC) Private Limited
Data last updated:
Prodev Pharma (OPC) Private Limited is a one person company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 21 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2018OPC129275. Its GSTIN is 36AAKCP2660A1ZO (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by director Venkata Naga Brahmeswara Rao Mandava.
Its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 2A By The Lake Apartments P.No 153 154 Vaishali Nagar Madinaguda, Hyderabad, Telangana, India – 500049.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.56 Cr, a decline of 45% compared to the previous year. For the same year it recorded a net loss of ₹1.54 Lakh (net margin -0.6%) and EBITDA of ₹4.25 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 21% over five years.
Prodev Pharma (OPC) Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0049521).
Company Details of Prodev Pharma (OPC) Private Limited
CIN U24100TG2018OPC129275
Registration Number 129275
Incorporation Date 21 December 2018
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-TS-02-0049521
Recognitions & Rankings of Prodev Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat No. 2A By The Lake Apartments P.No 153 154 Vaishali Nagar Madinaguda, Hyderabad, Telangana, India – 500049
- IndustryChemicals, Manufacturing, Basic Chemical
Comprehensive company report
Prodev Pharma (OPC) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Prodev Pharma (OPC) Private Limited
The main business activity of Prodev Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Prodev Pharma (OPC) Private Limited FY 2025 filings available
Prodev Pharma (OPC) Private Limited reported revenue of ₹2.56 Cr (down 45% YoY) for FY 2025.
Revenue · FY 2025
₹2.56 Cr ▼ 45%
Net loss · FY 2025
₹1.54 Lakh margin -0.6%
EBITDA · FY 2025
₹4.25 Lakh margin 1.7%
Compounded Annual Growth Rate (CAGR) of Prodev Pharma (OPC) Private Limited
Revenue CAGR growth
1 year
▼ 45%
3 years · compounded
▼ 34%
5 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▼ 59%
3 years · compounded
▼ 52%
5 years · compounded
▲ 39%
Revenue fell 45% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 21%. EBITDA fell 59% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Prodev Pharma (OPC) Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.25 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.54 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Prodev Pharma (OPC) Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Prodev Pharma are in the company report.
Premium access
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Prodev Pharma (OPC) Private Limited
Prodev Pharma has 1 director on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Naga Brahmeswara Rao Mandava | Director | 21 Dec 2018 | 7 Years 10 Months | Current |
Peer Comparison of Prodev Pharma (OPC) Private Limited
Prodev Pharma (OPC) Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| RRS Pharma & Surgical Twin Private Limited | ₹2.57 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Faridabad, Haryana, India |
| Aiton Healthcare Private Limited | ₹2.57 Cr (FY 2024) | •••• | •••• | 1349.0% | •••• | Varanasi, Uttar Pradesh, India |
| Flowrich Pharma Private Limited | ₹2.56 Cr (FY 2024) | •••• | •••• | 32.0% | •••• | Sion East, Maharashtra, India |
| Enomark Pharma Private Limited | ₹2.56 Cr (FY 2025) | •••• | •••• | 172.0% | •••• | Mumbai, Maharashtra, India |
| United Medisales Private Limited | ₹2.56 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
| Prodev Pharma (OPC) Private Limited this company | ₹2.56 Cr (FY 2025) | •••• | •••• | -45.0% | •••• | Hyderabad, Telangana, India |
| Cytoskinn Pharma Private Limited | ₹2.56 Cr (FY 2025) | •••• | •••• | •••• | Sanand, Gujarat, India | |
| German Homoeo Laboratories Private Limited | ₹2.56 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Kanpur, Uttar Pradesh, India |
| Petersburg Pharmaceutical Private Limited | ₹2.56 Cr (FY 2025) | •••• | •••• | 547.0% | •••• | Raigad, Maharashtra, India |
| Spider Facilities Private Limited | ₹2.55 Cr (FY 2021) | •••• | •••• | 21.0% | •••• | Navi Mumbai, Maharashtra, India |
| Gemmed Pharmaceuticals Private Limited | ₹2.55 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Vijayawada, Andhra Pradesh, India |
Peers are the five companies nearest above and the five nearest below Prodev Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Prodev Pharma (OPC) Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Prodev Pharma (OPC) Private Limited
Prodev Pharma (OPC) Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Prodev Pharma (OPC) Private Limited
Employment history and EPFO contributions of people linked to Prodev Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Prodev Pharma (OPC) Private Limited
Prodev Pharma (OPC) Private Limited has 1 board change on record since 2018: 1 appointment. The latest: Venkata Naga Brahmeswara Rao Mandava was appointed as Director on 21 Dec 2018.
Filing
Prodev Pharma (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Venkata Naga Brahmeswara Rao Mandava was appointed as Director.
Incorporation
21 Dec 2018
Prodev Pharma (Opc) Private Limited was registered on 21 Dec 2018 with Roc Hyderabad & aged 7 years 10 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Prodev Pharma (OPC) Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Prodev Pharma (OPC) Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Prodev Pharma (OPC) Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Prodev Pharma (OPC) Private Limited
Prodev Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAKCP2660A1ZO | Telangana | Active | 10 Jan 2019 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Prodev Pharma (OPC) Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prodev Pharma (OPC) Private Limited
Prodev Pharma is an active company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 21 December 2018 (8+ years old) and is registered under CIN U24100TG2018OPC129275.
Prodev Pharma reported revenue of ₹2.56 Cr for FY 2025 (down 45% YoY).
Prodev Pharma has 1 current director:
- Venkata Naga Brahmeswara Rao Mandava - Director
Prodev Pharma reported a net loss of ₹1.54 Lakh (net margin -0.6%) and EBITDA of ₹4.25 Lakh (EBITDA margin 1.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Prodev Pharma is -34% over three years and 21% over five years. In the latest year (FY 2025) revenue fell 45%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Prodev Pharma is 36AAKCP2660A1ZO, registered in Telangana.
The CIN (Corporate Identification Number) of Prodev Pharma is U24100TG2018OPC129275. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prodev Pharma was incorporated on 21 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Prodev Pharma by revenue are RRS Pharma & Surgical Twin Private Limited, Aiton Healthcare Private Limited, Flowrich Pharma Private Limited, Enomark Pharma Private Limited, United Medisales Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Venkata Naga Brahmeswara Rao Mandava was appointed as Director on 21 Dec 2018.
Yes, Prodev Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0049521).